{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Indrayani Biotech Ltd
Indrayani Biotech Ltd Falls to 52-Week Low of Rs.7.99 Amidst Continued Weakness
Indrayani Biotech Ltd’s stock declined sharply to a fresh 52-week low of Rs.7.99 on 5 Feb 2026, marking a significant downturn amid persistent financial headwinds and sectoral pressures. The stock’s fall comes despite a modest outperformance relative to its sector on the day, reflecting ongoing challenges in the company’s performance and valuation metrics.
Indrayani Biotech Ltd Falls to 52-Week Low Amid Continued Weakness
Indrayani Biotech Ltd’s stock price declined to a fresh 52-week low of Rs.8.5 today, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and benchmark indices, reflecting persistent financial pressures and subdued market sentiment.
Indrayani Biotech Ltd is Rated Strong Sell
Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 26 January 2026, providing investors with the latest insights into its performance and prospects.
Indrayani Biotech Ltd Falls to 52-Week Low Amidst Continued Underperformance
Indrayani Biotech Ltd’s shares touched a fresh 52-week low of Rs.8.56 today, marking a significant decline amid ongoing financial pressures and subdued market sentiment. This new low reflects a continuation of the stock’s downward trajectory over the past year, with the company’s performance lagging notably behind broader market indices.
Indrayani Biotech Ltd is Rated Strong Sell
Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 November 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Indrayani Biotech Ltd Falls to 52-Week Low Amid Continued Financial Struggles
Indrayani Biotech Ltd, a player in the Other Agricultural Products sector, recorded a fresh 52-week low of Rs.9.42 today, marking a significant decline in its stock price amid persistent financial headwinds and underwhelming market performance.
Indrayani Biotech Ltd Falls to 52-Week Low of Rs.9.6 Amidst Continued Weakness
Indrayani Biotech Ltd, a player in the Other Agricultural Products sector, has touched a new 52-week low of Rs.9.6 today, marking a significant decline in its stock price amid ongoing downward momentum and sectoral pressures.
Indrayani Biotech Ltd Falls to 52-Week Low Amidst Continued Weak Performance
Indrayani Biotech Ltd’s shares declined sharply to a fresh 52-week low of Rs.9.71 on 9 Jan 2026, marking a significant drop amid continued underperformance and weak financial metrics. The stock’s fall reflects ongoing pressures within the Other Agricultural Products sector and broader market headwinds.
Why is Indrayani Biotech Ltd falling/rising?
On 26-Dec, Indrayani Biotech Ltd witnessed a notable decline in its share price, falling by 3.23% to close at ₹12.90. This movement reflects a continuation of the stock’s downward trajectory amid broader sectoral weakness and subdued investor participation.
Indrayani Biotech Ltd is Rated Strong Sell
Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 25 December 2025, providing investors with the latest comprehensive view of the company’s position.
Are Indrayani Biotec latest results good or bad?
Indrayani Biotech's latest Q2 FY26 results show a net profit of ₹0.91 crores, a significant recovery from the previous quarter but a 25.41% decline year-on-year. While revenue grew, the company faces severe margin pressures and operational challenges, raising concerns about the sustainability of its profitability.
Indrayani Biotech Reports Flat Quarterly Performance Amid Challenging Market Conditions
Indrayani Biotech's latest quarterly results for September 2025 reveal a stabilisation in financial performance following a period of decline, with key metrics showing a shift from negative trends to a more neutral footing. Despite ongoing challenges in profitability and market returns, the company’s recent figures offer a nuanced view of its operational and financial health within the Other Agricultural Products sector.
Indrayani Biotech Q2 FY26: Profit Recovery Masks Deepening Operational Crisis
Indrayani Biotech Ltd., a micro-cap agricultural products company, reported a consolidated net profit of ₹0.91 crores in Q2 FY26, marking a dramatic 468.75% quarter-on-quarter surge from ₹0.16 crores in Q1 FY26. However, this apparent recovery conceals a troubling reality: year-on-year profit declined 25.41%, whilst the company's operating margins collapsed to just 6.82%, down sharply from 23.76% in the corresponding quarter last year. The stock, currently trading at ₹14.31 with a market capitalisation of ₹63.00 crores, has plummeted 60.46% over the past year, reflecting deep investor scepticism about the company's operational viability.
Indrayani Biotec Sees Revision in Market Assessment Amidst Challenging Fundamentals
Indrayani Biotec, a microcap player in the Other Agricultural Products sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The recent assessment highlights concerns across multiple parameters, signalling a cautious outlook for investors.
How has been the historical performance of Indrayani Biotec?
Indrayani Biotec's historical performance has been volatile, with net sales declining from 166.23 Cr in March 2024 to 130.23 Cr in March 2025, resulting in significant losses, including a profit after tax of -6.11 Cr in March 2025 compared to 10.42 Cr the previous year. The company's earnings per share also fell from 1.4 to -1.34 during this period.
Are Indrayani Biotec latest results good or bad?
Indrayani Biotech's latest results are concerning, with a 7.71% decline in net sales and significant drops in profitability, including an 81.18% reduction in Profit After Tax. The company faces operational challenges, liquidity issues, and increased reliance on debt.
Why is Indrayani Biotec falling/rising?
As of 13-Nov, Indrayani Biotech Ltd's stock price is 14.78, down 1.92%, and has declined 65.14% over the past year. The stock is underperforming compared to the broader market, with significantly reduced investor interest and mixed short-term momentum indicators.
Why is Indrayani Biotec falling/rising?
As of 06-Nov, Indrayani Biotech Ltd's stock price is at 15.60, having increased by 9.4% recently. Despite strong short-term gains, the stock remains down 57.12% year-to-date, indicating significant underperformance compared to the Sensex.
Why is Indrayani Biotec falling/rising?
As of 27-Oct, Indrayani Biotech Ltd's stock price is Rs 13.86, down 7.41%, with significant declines over the past week and year-to-date. The stock's poor performance is attributed to negative sector sentiment and reduced investor participation.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
